GHRP-2

GHRP-2 and growth hormone releasing peptide-2, also known as KP 102 - a commercially synthesized hexapeptide growth hormone releasing. This superanalogue peptide GHRP-2, which has a powerful stimulating effect on the production of growth hormone and easy stimulatory effect on prolactin, adrenocorticotropic hormone and cortisol levels.

Purity (HPLC readings): at least 99%.
Volume 5 mg vial.

Product Description

Molecular formula: C45H55N9O6
Molecular Weight: 817.9
The amino acid sequence: H-D-Ala-D-Nal-Ala-Trp-D-Phe-Lys-NH2

ONLY FOR RESEARCH PURPOSES
GHRP-2 has a powerful effect on the body's natural production of endogenous human growth hormone. GHRP-2 stimulates the production of growth hormone in daily sublingual use of the drug. GHRP-2 very quickly increases the level of insulin-like growth hormone-1, and if it combined with GHRH (Sermorelin, CJC-1295 GHRH-1-44 et al.), The results will be even better, because such mixture stimulates the pituitary gland to produce a lot more of the hormone human growth. The peptide stimulates the performance of both the hypothalamus and the pituitary gland.
GHRP-2 - a true stimulant of growth hormone secretion. This means that the peptide contributes to the development of self-growth hormone by the body. Human growth hormone helps the body keep the right weight to it, avoiding obesity. GHRP-2 demonstrated the effectiveness of the stimulation of growth hormone research. In short half-life of the peptide, the peak concentrations lasted approximately 15 minutes but no more than 60 minutes after application. It is a synthetic peptide also grelinic receptor agonist binding to the receptor-stimulator of growth hormone. GHRP-2 increases the production of growth hormone. Please pay attention to Libidon.The natural physiological system from exposure to the peptide increases levels and inflow of calcium ions produce the level of growth hormone. Chemical structure and properties of the peptide are described below.

dosing study medication showed that the analogue of its strength similar to growth hormone releasing factor, and ten times more powerful than the previous generation of substances which release growth hormone, such as growth releasing peptide-1 and 6 (Wu and dr.1994). Because of this effect, the hormone used to treat defective conditions in monkeys and catabolic states. Studies and other Laferra (2005) showed that GHRP-2 acts as a ghrelin causing starvation in monkeys and stimulating the secretion of growth hormone. A similar impact was illustrated by the increased levels of growth hormone during GHRP-2 injection (AUC 5550 ± 1090 μg / L / 240 min vs. 412 ± 161 μg / L / 240 min, p = 0.003). Also, peptide-2 increases the secretion of cAMP in cells. Its effect is in this case similar to the action of growth hormone releasing factor.
GHRP-2 is also provided an anti-inflammatory effect on arthritis in rats using a ghrelin receptor acted directly on immune cells (Granado et al, 2004). However, it is important to note that the level of results GHRP-2 action varies according to animal species. Especially it is different in the reaction cell pituitary somatotrophs, probably because there is a difference between subtypes of receptors of growth hormone releasing peptides (Wu et al, 1996). However, the action of GHRP-2 is blocked in a physiological system receptors growth hormone releasing factor, which in turn acts via a different receptor that was used earlier versions growth releasing peptides.